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Objectives: The present study was carried out to evaluate the 
immunomodulatory efficacy of Karanja (Pongamia pinnata Pierre) Seed 
Churna in aqueous solution. Methods: The animals for this trial were rats 
of either sex and blood that was used was sheep’s blood. The study was 
conducted in three groups having 6 rats in each group. First group was 
control group and tap water was administered to this group orally, 
second and third group received the test drug aqueous solution at the 
dose 800mg and 4000mg/kg body weight respectively for 10 consecutive 
days. The test drug was evaluated for effect on humoral antibody 
formation, on cell mediated immunity and spleen and thymus weight 
gain. Histopathological studies were also performed on spleen and 
thymus in SRBC pre-sensitized rats. Results: The data on the effect of test 
drug on antibody formation against sheep red blood cells shows marginal 
statistically non-significant decrease in antibody titre at both lower and 
higher dose levels. Cell mediated immunity only at higher dose level in 48 
hours reached statistically significant level whereas non-significant 
changes were observed in the weight of spleen and thymus. Conclusion: 
Karanja seed possess significant cell mediated immunity and non-
significant effect on antibody formation and also non-significant effect on 
spleen and thymus weight gain. 
 
INTRODUCTION 
 Pharmacology is the science of drugs. In a 
broad sense, it deals with interaction of exogenous 
administered chemical molecules (drugs) with the 
living systems.[1] The object of Pharmacology is to 
provide a scientific foundation for therapeutics and 
to increase the resources of the art of healing the 
exact way in which a drug changes the diseased 
condition can often be followed only imperfectly in 
man and hence, recourse has to made to 
experiments on healthy or diseased animals to 
elucidate the principles on which it should be 
employed. Knowledge of the mode of action of a 
drug obviously greatly enhances prediction from 
animal studies of what happened in man. 
Experimental study and the clinical study are the 
two aspects of the drug research. Experimental 
study can give us the better idea about the exact 
properties and action of the drugs. Moreover, there 
is a need to explain the drug activity in terms of 
current modern medical concepts by employing 
suitable experiments and methods so that the 
Ayurvedic means and methods are accepted 
globally. Further it also ensures scientific validation 
of Ayurvedic concepts and drugs. Karanja 
(Pongamia pinnata Pierre) is one of the well-known 
medicinal plants growing everywhere in India. It 
has been advocated in treating a broad range of 
diseases. The Ayurvedic treatises appreciated the 
therapeutic activities of this plant particularly in 
skin diseases.[2] In the present study an effort has 
been made to study the immunomodulatory 
properties of the Karanja in experimental animals. 
Immuno-modulation is modulation (regulatory 
adjustment) of the immune system. It has natural 
and human-induced forms, and thus the word can 
refer to the following: Homeostasis in the immune 
system, whereby the system self-regulates to adjust 
immune responses to adaptive rather than 
maladaptive levels (using regulatory T cells, cell 
signaling molecules, and so forth). Immuno-
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modulation as part of immunotherapy, in which 
immune responses are induced, amplified, 
attenuated, or prevented according to therapeutic 
goals.[3] 
Aims and objectives 
 To study the immunomodulatory activity of 
aqueous solution of Karanja seed Churna (powder) 
which includes the study of its effect on humoral 
antibody formation, effect on spleen and thymus 
weight and its effect on cell mediated immunity. 
Materials and methods 
Drug material 
 The drug Pongamia pinnata Pierre, seed 
powder (Churna) sample was supplied by 
Pharmacy, Gujarat Ayurveda University, Jamnagar 
and identified and authenticated in Pharmacognosy 
laboratory. For administering to the experimental 
animals, a drug suspension was made with requisite 
quantity of distilled water according to the dose 
required. 
Animals 
 Swiss albino mice and Charles Foster strain 
albino rats were obtained from the animal house 
attached to the I.P.G.T.R.A, Gujrat Ayurveda 
University, Jamnagar. The animals were maintained 
on Navchakan Oil Mills, “Amrut” Brand rat pellets 
feed and tap water given ad libitum. The animals 
were maintained under normal ambient conditions. 
Each experimental group consisted 6 rats of either 
sex. Control group received equal quantity of the 
Vehicle (distilled water) used for the preparation of 
the test drug suspension. 
Chemicals 
 Sheep blood was collected fresh from the 
local slaughter house in a sterile glass bottle 
containing autoclaved ACD solution. 
Instruments used 
 Sterilizer, surgical instruments, cotton, 
syringes, needles, centrifuge, refrigerator, feeding 
syringes and tubes, serological water bath, vortex 
mixer, Alserver’s solution, formaldehyde solution, 
haemotoxylin and eosin stain, haemagglutination 
titre tray, microtiter plates and picric acid. 
Route of administration 
 The drug was administered by oral route 
with the help of a gastric catheter sleeved on to a 
syringe. The dose of the drug was calculated by 
extrapolating the human dose to animals based on 
the body surface area ratio by referring to the 
standard table of Paget and Barnes (1994). [4] 
Statistical analysis 
Student’s ‘t’ test for unpaired data has been used for 
analyzing the data generated during the study.[5] 
Immunomodulation Activity 
Effect on Humoral Antibody Formation 
 Rats of either sex in the body weight ranges 
between 160-254 g were used in the present study. 
Three groups each with six rats were included. First 
group was kept as control and tap water was 
administered by oral route. Second group was kept 
as a high dose group, received Karanja seed in a 
dose of 800 mg/ kg body weight daily for 10 
consecutive days, while group third was kept as a 
low dose group and was administered Karanja seed 
in a dose of 400 mg per kg body weight in aqueous 
solution. On the third day of test drug 
administration sensitizing agent was injected intra-
peritoneally. Sensitizing agent used was sheep red 
blood corpuscles (30% v/v) in the dose of 10 ml per 
kg body weight. Sheep blood was collected 
aseptically from the city slaughter house in a 
sterilized bottle containing ACD solution. SRBC 
were thoroughly washed with sterile normal saline 
and stored in Alserver’s solution in a refrigerator 
till experimentation. Blood from sterile animal was 
used both for sensitizing and to determine antibody 
titre. On the eleventh day, rats were sacrificed by 
cervical dislocation and blood was collected. Serum 
was separated from it and complement in it was 
inactivated by heating at 56 degree Celsius for 30 
minutes in serological water bath. Serial two folds 
dilutions of the serum in sterile saline solution were 
made in the volume of 0.1 ml in micro-titreplate. 0.1 
ml of thrice saline washed 2% SRBC was added to 
each well. The trays were covered and placed in a 
refrigerator overnight. Haemagglutination titre 
with SRBC were prepared (Fig. 1). 
Haemagglutination titre was noted and titres were 
converted to Log 2 values for easy comparison. 
Spleen and thymus were also dissected out 
immediately after the rats were sacrificed. After 
noting the weight the tissues were transferred to 10 
% formaldehyde solution for fixation and later on 
processed for histological studies following 
standard procedures as described in NIN manual.[6] 
Microtome sections were cut, processed and stained 
with haemotoxylin and eosin. The sections thus 
obtained were scanned in a binocular research 
microscope under different magnifications. Changes 
if any in the cyto- architecture were noted down. 
Effect of test drug on cell mediated immunity 
 Unlike antibody mediated immune 
response, which is mediated through the formation 
of antibody by the plasma cells, in cell-mediated 
immunity T-Lymphocyte directly react with antigen 
to cause its destruction. Cell mediated immunity is 
also mediated by release of lymphokines, antibodies 
and complement are not involved in these 
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reactions. This phenomenon is responsible for the 
rejection of foreign cells. Organ transplantation is 
one such reaction. 
 The test drug was evaluated to assess its 
effect on cell- mediated immunity by noting its 
effect on immunological inflammation produced by 
pedal injection of a suspension of SRBC. SRBC was 
thoroughly washed with sterilized normal saline by 
centrifuging and stored in Alserver’s solution in a 
refrigerator till experimentation. Sterile thrice 
washed 4% SRBC suspension was injected 0.5 ml 
per 100 g body weight to each rat on the first day of 
drug administration. The drug treatment was 
continued for six days. Injecting 0.05 ml of similar 
suspension in the right hind paw on the sixth day of 
sensitization induced immunological oedema. 
Volume of the oedema was measured by volume 
displacement method (Bhatt et al 1977)[7], before 
sensitization, 24 and 48 hours after the second 
injection of SRBC into hind paw. Percentage 
increase over initial value was calculated. The 
values from control group were compared to test 
drug administered group to ascertain whether the 
drug modulates cell- mediated immunity or not. 
RESUTS AND OBSERVATIONS 
(A) Effect on antibody formation 
 The data on the effect of test drug on 
antibody formation against sheep red blood cells 
(SRBC has been presented in table 1). 
Table 1: Effect of Karanja seed Churna on antibody formation against SRBC in rats 
Group  Dose mg/kg Antibody titre (log2 values) 
Control - 6.01±0.42 
Karanja seed Churna 400 5.89±0.64 
Karanja seed Churna 800 5.77±0.49 
Data: mean ±S.E.M. 
A marginal statistically non-significant decrease in antibody titre was observed at both lower and higher 
dose levels. Decrease was more in higher dose level in comparison to lower dose level. 
A) Effect on spleen and thymus weight 
The data on the effect of test drug on the weight of spleen and thymus has been presented in table 2 
Table 2: effect of Karanja seed Churna on spleen and thymus in SRBC pre- sensitized rats 







  Absolute (g) Relative (g/100g 
body weight) 
Absolute (g) Relative (g/100g 
body weight) 
Control  - 0.324±0.15 0.174±0.007 0.506±0.042 0.269±0.002 
Karanja seed Churna 400 0.348±0.020 0.198±0.015 0.543±0.06 0.278±0.003 
Karanja seed Churna 800 0.388±0.24 0.198±0.0008 0.693±0.04 0.356±0.04 
Data: mean ±S.E.M. 
 The values have been presented in both in terms of absolute as well as relative values. a apparent 
increase in spleen weight and thymus weight was observed both with respect to absolute and relative values 
in lower dose as well as higher dose level. However, none of the values in both the groups reached 
statistically significant levels. Increase in weight was more in higher dose level than in lower dose level, 
except in relative spleen weight, where the increase was the same in both the groups. 
B) Effect on cell mediated immunity 
 The effect of Karanja seed Churna on cell mediated immunity was evaluated by noting the effect of 
its administration on 4% SRBC induced pedal oedema in pre-senstized rats. The data pertaining to the test is 
presented in table 3. 
Table 3: Effect of Karanja seed Churna on 4% SRBC induced and hind paw oedema in pre sensitized 
rats 
Group  Dose mg/kg Percentage increase in paw volume 
  24 hours 48 hours 
Control   28.77±4.03 7.31±0.81 
Karanja seed Churna low dose  400 23.73±4.71 2.60±1.86 
Karanja seed Churna high dose 800 14.73±6.42 1.85±1.85* 
Data: mean ±S.E.M. *P<0.05 
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 At the lower dose level, 17.51% decrease in 
paw oedema in 24 hours and 64.43% decrease in 48 
hours was observed whereas at higher dose level, 
48.80% decrease in 24 hours and 74.69% decrease 
in 48 hours was observed. However, only one value 
at higher dose level in 48 hours reached statistically 
significant level (p<0.05). 
C) Histopathological Studies 
The following observations were made on 
histopathological study of spleen and thymus in 
SRBC pre-sensitized rats. 
a) Spleen  
 Photomicrographs of sections of spleen 
obtained from different groups are presented in Fig. 
2a, 2b, 12c. In lower dose drug administered group 
9 (Fig 1b), increase in proportion of white pulp was 
observed in comparison to spleen sections from 
control rats (Fig 2a), whereas no change could be 
observed at higher dose level (Fig2c). 
b) Thymus  
 Fig. 3a, 3b and 3c depict photomicrographs 
of sections of thymus obtained from different 
groups. In the group receiving 400 mg/ kg dose of 
Karanja seed Churna (Fig. 3 b), moderate increase 
in cellularity and vacuolization were observed. In 
800 mg/kg dose given group (Fig. 3c), increase in 
cellularity was observed. 
DISCUSSION 
 The Karanja seed Churna did not produce 
significant decrease in the antibody titre against 
SRBC in rats. However, significant antagonism of 
immunological paw oedema was observed at higher 
dose level. Moderate increase in spleen weight and 
thymus weight was observed at higher dose level. 
In cell mediated immunity, foreign antigen is 
processed and presented to CD4helper T-cell which 
elaborate IL-2 and other cytokines that in turn 
stimulate proliferation and maturation of precursor 
cytotoxic lymphocytes, that have been activated by 
antigen presented with class-I major histo-
compatibility complex. The mature CTL (killer cells) 
recognize cells carrying the antigen and lyse them. 
Another sub-populations of T-lymphocytes termed 
suppressor cells modulate the functioning of the 
other lymphocytes by elaborating tonic inhibitors. If 
their action is inhibited, it will lead to immuno-
stimulation and if their functioning is enhanced, it 
may lead to immuno- suppression. It can be 
suggested that the test drug may have some 
modulatory effect on suppressor T-cells. As 
described above, there are many potential sites for 
drug action. It is possible that the test drug may 
contain active principles, which modulate immune 
response by acting at one of the above potential 
sites. 
CONCLUSION 
 Results of the present study clearly show 
that Karanja (Pongamia pinnata Pierre) seed 
possess significant cell mediated immunity and 
non- significant decrease in antibody titre against 
SRBC in rats. The increase in weight of spleen and 
thymus was also non- significant. However, some 
increase in weight and antibody titre was observed 
at higher doses. 
 
 
Fig. 1- Showing haemagglutination titre with SRBC 
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Fig. 2a: Photomicrograph of section of spleen from control SRBC sensitized rats (I X 32 magnification)  
Wp: white pulp Rp: red pulp Cp: capsule (Note : Slightly increased proportion of white pulp) 
 
 
Fig. 2b: Photomicrograph of section of spleen from lower dose Karanja Seed administered SRBC 
sensitized group 
(I X 32 magnification) Wp: white pulp Rp: red pulp Cp: capsule (Note : increased proportion of white pulp) 
 
Fig. 2c: Photomicrograph of section of spleen from higher dose Karanja Seed administered SRBC 
sensitized group. 
(I X 32 magnification) Wp: white pulp Rp: red pulp Cp: capsule (Note : Normal cyto-architecture) 
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Fig. 3a: Photomicrograph of section of thymus from control SRBC sensitized group. 
(I X 100 magnification) 
C: Cortex M: Medulla; B.V.: Blood vessel (Note : Normal cyto-architecture) 
 
Fig. 3b: Photomicrograph of section of thymus from lower dose Karanja Seed administered SRBC sensitized 
group. (I X 32 magnification) control SRBC sensitized group. 
C: Cortex M: Medulla; B.V.: Blood vessel 
 
Fig. 3c: Photomicrograph of section of thymus from higher dose Karanja Seed administered SRBC sensitized 
group. (I X 100 magnification) control SRBC sensitized group. 
C: Cortex M: Medulla B.V.: Blood vessel (Note : increased cellularity) 
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